Suchergebnisse - (Subject:"ritonavir")

PubPharm (33)

1

Raltegravir versus lopinavir/ritonavir for treatment of HIV-infected late-presenting pregnant women

enthalten in: HIV clinical trials | 2018

von Brites, C. | Nóbrega, I. | Luz, E. | +3

2

Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practice

enthalten in: HIV clinical trials | 2018

von Pineda, J. | Rivero-Juárez, A. | de Los Santos, I. | +11

3

Atherogenic properties of LDL particles after switching from Truvada or Kivexa plus lopinavir/r to lamivudine plus lopinavir/r : OLE-MET substudy

enthalten in: HIV clinical trials | 2017

von Saumoy, M. | Tiraboschi, J. | Ordoñez-Llanos, J. | +6

4

Efficacy and safety of "unboosting" atazanavir in a randomized controlled trial among HIV-infected patients receiving tenofovir DF

enthalten in: HIV clinical trials | 2017

von Harris, M. | Ganase, B. | Watson, B. | +5

5

Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection : the REMAIN Study

enthalten in: HIV clinical trials | 2016

von Teófilo, E. | Rocha-Pereira, N. | Kuhlmann, B. | +69

6

Regimen selection in the OPTIONS trial of HIV salvage therapy : drug resistance, prior therapy, and race-ethnicity determine the degree of regimen complexity

enthalten in: HIV clinical trials | 2015

von Tashima, K. | Mollan, K. | Na, L. | +8

7

A pilot, prospective, open-label simplification study to evaluate the safety, efficacy, and pharmacokinetics of once-daily lopinavir-ritonavir monotherapy in HIV-HCV coinfected patients : the MONOCO study

enthalten in: HIV clinical trials | 2012

von Cooper, C. | la Porte, C. | Tossonian, H. | +3

8

Simplified maintenance therapy with abacavir/lamivudine and atazanavir after discontinuation of ritonavir

enthalten in: HIV clinical trials | 2010

von Elion, R. | Berger, D. | Richmond, G. | +14

CommentOn: HIV Clin Trials. 2008 May-Jun;9(3):152-63. - PMID 18547902

9

Safety and efficacy of a 36-week induction regimen of abacavir/lamivudine and ritonavir-boosted atazanavir in HIV-infected patients

enthalten in: HIV clinical trials | 2010

von Squires, K. | Young, B. | DeJesus, E. | +78

10

Study of once-daily versus twice-daily fosamprenavir plus ritonavir administered with abacavir/lamivudine once daily in antiretroviral-naïve HIV-1-infected adult subjects

enthalten in: HIV clinical trials | 2009

von Carosi | Lazzarin | Stellbrink | +9